Chemicals & Advanced Materials

In-Situ Hybridization Market to Grow by 5.4% CAGR by 2024 | A report by Medtronic, General Electric Company, Siemens AG, Brainlab AG, Koninklijke Philips NV, IMRIS Deerfield Imaging and others

Medtronic (Ireland), General Electric Company, Siemens AG, Brainlab AG,  Koninklijke Philips NV, IMRIS Deerfield Imaging, NeuroLogica Corporation, Ziehm Imaging GmbH, Toshiba Corporation, Shimadzu Corporation, Neurologica Corporation, Imris are turning heads in the In situ hybridization market owing to their product launches, researches, joint ventures, mergers, and accusations. The In situ hybridization report brings you all the company profiles required to be in the competition for the In situ hybridization market. With the help of SWOT analysis, this report informs you about all the market restrain and drivers to be followed in the forecast years 2019-2024 while explaining the In situ hybridization market’s definition, classifications, applications, and engagements.

Market Analysis:

The In Situ Hybridization Market accounted to USD 550.0 million in 2016 growing at a CAGR of 5.4% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get Sample Report at:

Key Competitors:

  • Medtronic (Ireland)
  • General Electric Company
  • Siemens AG
  • Brainlab AG
  • Koninklijke Philips NV
  • IMRIS Deerfield Imaging
  • NeuroLogica Corporation
  • Ziehm Imaging GmbH
  • Toshiba Corporation
  • Shimadzu Corporation
  • Neurologica Corporation
  • Imris Inc. among others.

Get Detailed TOC

Market Drivers and Restraints:

  • Increasing prevalence of cancer disease
  • Increasing diagnosis of cancer disease
  • Advancement in therapeutics technology
  • Rising government initiatives
  • Increasing demand of accurate prognostic tools
  • Increasing healthcare expenditure

Market Segmentation:

By product type the In situ Hybridization market is segmented into

  • Flurocent In-Situ Hybridization (FISH)
  • Chromogenic In-Situ Hybridization (CISH)

Flurocent In-Situ Hybridization is further segmented into

  • DNA – FISH
  • RNA – FISH

Chromogenic In-Situ Hybridization is further segmented into

  • DNA – CISH
  • RNA – CISH

By application the market is segmented into

  • cell biology research
  • neuroscience
  • oncology and others

On the basis of end user the market is segmented into

  • pharma and biotechnology laboratories
  • research and academics
  • hospitals and others

On the basis of geography, In situ Hybridization market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major companies covered in this report are Agilent Technologies, Thermo Fisher Technologies, Affymetrix, Abbot Laboratories, Vector Laboratories, Inc., Advanced Cell Diagnostics, Nordic BioSite AB, Abcam Plc, Genemed Biotechnologies, Inc., Sigma-Aldrich Co. LLC, BioVisible BV, PerkinElmer Inc., Abnova Corporation, Enzo Life Sciences Inc., Bio SB, Elchrom Scientific AG among other companies.

Competitive Analysis:

In situ Hybridization market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of In situ Hybridization market for global, Europe, North America, Asia Pacific and South America.

Speak to Author



Related Articles